Novartis ag NVS.US Overview Analysis
)NVS AI Analysis Overview
Keys for Bullish View
- Value≥4
- Dividend≥2
Analysis Conclusion
The stock excels in value rating and ranks among the top in dividend scores. It's a prime choice for long-term accumulation. For optimal entry, check our trend and swing trading ratings.
NVS Current Performance
-1.06%
Novartis ag
1.99%
Avg of Sector
-0.64%
S&P500
Top 10 High Relevance to NVS
- AZN Astrazeneca plcValue 4Trend 3Swing Trading 5Whale Interest 2Dividend 5See more
NVS Profile
Novartis AG is a Switzerland-based pharmaceutical company. The Company develops, manufactures, and markets branded and generic prescription drugs, active pharmaceutical ingredients (APIs), biosimilars and ophthalmic products. The Company uses science and digital technologies for treatments in the disease areas of immunology, dermatology, cancer, ophthalmology, neuroscience, respiratory, cardiovascular, renal and metabolism. The business activities of the Company are divided into two segments: Innovative Medicines, which includes innovative patent-protected prescription medicines for blood pressure, cancer and other ailments, and Sandoz, which includes generic pharmaceuticals and biosimilars.